Passion for Health
삼성바이오에피스는 더 많은 환자들에게 고품질의 바이오의약품을 합리적인 가격으로 사용할 수 있는 기회를 제공하기 위해 최선을 다하고 있습니다.
News & Stories
삼성바이오에피스의 최신 소식과 이야기를 만나보세요.
NEWS
Jun 4, 2025
May 30, 2025
May 29, 2025
May 14, 2025
Cancer survival rates are set to rise thanks to improved access to treatment. At Samsung Bioepis, we support this progress with quality-assured biosimilars whic...
Jun 2, 2025
At Samsung Bioepis, our mission is to expand access to high-quality biologic treatments across a wide range of therapeutic areas. We believe access to treatment...
May 28, 2025
We are pleased to announce that our adalimumab biosimilar has been granted interchangeability designation by the @US_FDA across all approved presentations.
May 27, 2025
Totality of evidence (ToE) serves as the foundation for confidence in biosimilars.
May 22, 2025
Clinical trials power innovation, bring new hope to patients, and help shape the future of healthcare.
May 20, 2025
Inflammatory bowel disease, or #IBD, is not just about abdominal pain—it is a complex autoimmune disease. This World IBD Day, Samsung Bioepis reaffirms its comm...
May 19, 2025
LINKEDIN
Cancer survival rates are set to rise—and improved access to treatment is a big reason why. At Samsung Bioepis, we support this progress with quality-assured bi...
We are pleased to announce that our adalimumab biosimilar has been granted interchangeability designation by the FDA across all approved presentations
Totality of evidence (ToE) serves as the foundation for confidence in biosimilars. Find out how in the second edition of Biosimilars Explained.
Inflammatory bowel disease, or IBD, is not just about abdominal pain—it is a complex autoimmune disease. This World IBD Day, Samsung Bioepis reaffirms its commi...
Join Us
삼성바이오에피스는 미래를 이끌어갈 인재를 기다리고 있습니다.
오늘 하루 그만보기 닫기
삼성바이오에피스 홈페이지에서 당사 소셜미디어 사이트로 이동하시겠습니까?